CIAM
PROF

Caitong International Asset Management’s Profound Medical PROF Stock Holding History

Caitong International Asset Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$622 Buy
+96
New +$663 ﹤0.01% 1575

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Caitong International Asset Management's PROF Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Profound Medical (PROF) in Q1 2026: 96 shares worth $622. The stake represents ﹤0.01% of the portfolio and ranks #1575 among its holdings.

57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Caitong International Asset Management held 96 shares of Profound Medical worth $622 as of Q1 2026.
  • Profound Medical was a new Caitong International Asset Management position in Q1 2026.
  • Profound Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1575 holding.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.